| Authors: |
Wohlleben J; KNCV Tuberculosis Foundation, Evidence team, The Hague, The Netherlands.; Department of International Health, University Maastricht, Maastricht, The Netherlands., Makhmudova M; KNCV TB Foundation, country office Tajikistan, Dushanbe, Tajikistan., Saidova F; KNCV TB Foundation, country office Tajikistan, Dushanbe, Tajikistan., Azamova S; Republican Center for protection of population from TB, Dushanbe, Tajikistan., Mergenthaler C; KNCV Tuberculosis Foundation, Evidence team, The Hague, The Netherlands.; Present address: Royal Tropical Institute (KIT), Amsterdam, The Netherlands., Verver S; KNCV Tuberculosis Foundation, Evidence team, The Hague, The Netherlands. s.verver@erasmusmc.nl.; Academic Medical Centre, AIGHD, Amsterdam, the Netherlands. s.verver@erasmusmc.nl.; Present address: Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. s.verver@erasmusmc.nl. |